LATEST NEWS Q4 Investors Conference Call December 2, 2021 | 8am ET JOIN US Jefferies London Healthcare Conference Fireside Chat November 18, 2021 WATCH REPLAY Listen to other presentations and conference calls Nov 18, 2021 Veru to Report Fiscal 2021 Fourth-Quarter, Full-Year Financial Results, Host Conference Call on December 2nd Nov 18, 2021 Veru Ranked as one of the Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500 Nov 8, 2021 Veru to Participate in Fireside Chat at the Jefferies London Healthcare Conference on November 16-18, 2021 MORE NEWS VERU PIPELINE Sabizabulin Prostate Cancer Sabizabulin Prostate Cancer A novel oral selective antitubulin that targets alpha and beta tubulin for metastatic prostate cancer as well as for other forms of advanced cancers. LEARN MORE Sabizabulin COVID-19 Sabizabulin COVID-19 Novel Microtubule Depolymerization Drug with Dual Mechanism of Action – Antiviral for SARS-COV-2 & Anti-Inflammatory for Cytokine Storm LEARN MORE VERU-100 Prostate Cancer VERU-100 Prostate Cancer VERU-100 is a novel, proprietary peptide formulation designed with multiple beneficial clinical attributes addressing the shortfalls of the current multi-billion-dollar androgen deprivation therapy market for advanced prostate cancer. LEARN MORE Tadalafil 5mg and Finasteride 5mg combination tablet (TADFIN™) Tadalafil 5mg and Finasteride 5mg combination tablet (TADFIN™) TADFIN™ combination of a PDE5 inhibitor and 5 alpha reductase inhibitor for the treatment of enlarged prostate (BPH) LEARN MORE Enobosarm Enobosarm Enobosarm, selective androgen receptor targeting agonist, for the treatment of estrogen receptor positive (ER+) and human epidermal growth factor receptor 2 (HER2-) metastatic breast cancer. LEARN MORE Sabizabulin for Triple Negative Breast Cancer Sabizabulin for Triple Negative Breast Cancer Sabizabulin, an oral, first-in-class alpha and beta tubulin inhibitor/cytoskeleton disruptor small molecule, for the treatment of taxane resistant metastatic triple negative breast cancer. LEARN MORE ABOUT VERU About Pipeline Investors MIAMI | LONDON | MALAYSIA © 2021 Veru Inc. | All Rights Reserved | Accreditation and Certificates | Privacy Policy | Anti-Trafficking Policy | Terms of Use | Contact Us Website Design by Get Sharp, Inc.